Harrow reported a $20 million loss for the first half of 2024, doubling from the previous year. Increased competition from generics and new drugs will squash margins. Harrow's recent strategy shift ...
Good morning, and welcome to Harrow's Third Quarter 2024 Earnings Conference Call. My name is Michelle, and I will be your operator for today's call. At this time all participants are in a listen-only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results